MeSH term
Frequency | Condition_Probility | Base Sequence | 26 | 0.0 |
DNA Primers | 7 | 0.0 |
DNA-Binding Proteins/*metabolism | 41 | 1.0 |
Humans | 168 | 0.0 |
Interferon Type I/*metabolism | 5 | 31.0 |
Receptors, Interferon/chemistry/*metabolism | 3 | 50.0 |
Trans-Activators/*metabolism | 41 | 4.0 |
Tumor Cells, Cultured | 46 | 0.0 |
Tyrosine/*metabolism | 5 | 1.0 |
Cell Division/drug effects | 12 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics/*metabolism | 2 | 5.0 |
Dimerization | 12 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Gene Expression/drug effects | 4 | 0.0 |
Interferon Type I, Recombinant/*pharmacology | 7 | 14.0 |
Research Support, U.S. Gov't, P.H.S. | 89 | 0.0 |
Trans-Activators/chemistry/*genetics/*metabolism | 2 | 11.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
3T3 Cells | 5 | 0.0 |
Animals | 70 | 0.0 |
Cell Line | 61 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 9 | 0.0 |
Interferon-alpha/metabolism/*pharmacology | 3 | 37.0 |
Mice | 32 | 0.0 |
Parainfluenza Virus 2, Human/physiology | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 121 | 0.0 |
Species Specificity | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 9 | 2.0 |
Baculoviridae/genetics | 2 | 1.0 |
*Nuclear Localization Signal | 2 | 6.0 |
Phosphorylation | 57 | 0.0 |
Protein Binding | 21 | 0.0 |
Spodoptera | 4 | 1.0 |
Tyrosine/metabolism | 24 | 2.0 |
alpha Karyopherins/*metabolism | 2 | 66.0 |
Active Transport, Cell Nucleus | 7 | 2.0 |
Cell Nucleus/metabolism | 15 | 0.0 |
Cells, Cultured | 24 | 0.0 |
DNA-Binding Proteins/metabolism | 26 | 1.0 |
Kinetics | 14 | 0.0 |
Phosphoproteins/metabolism | 6 | 0.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 16 | 1.0 |
Proteins/metabolism | 10 | 1.0 |
*Signal Transduction | 22 | 1.0 |
Trans-Activators/metabolism | 26 | 2.0 |
Dose-Response Relationship, Drug | 11 | 0.0 |
Interferon-beta/*pharmacology | 6 | 10.0 |
Jurkat Cells | 5 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Receptors, Interferon/metabolism | 7 | 17.0 |
Signal Transduction | 37 | 0.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
DNA-Binding Proteins/physiology | 4 | 1.0 |
Trans-Activators/*physiology | 3 | 1.0 |
Transcription Factors/physiology | 2 | 0.0 |
Cercopithecus aethiops | 6 | 0.0 |
Down-Regulation | 4 | 0.0 |
Interferon Type I/*pharmacology | 6 | 12.0 |
Trans-Activators/physiology | 4 | 2.0 |
Interferon-alpha/metabolism | 6 | 27.0 |
Interferon-beta/metabolism | 7 | 36.0 |
Rubulavirus/*pathogenicity/physiology | 2 | 100.0 |
Viral Proteins/metabolism | 4 | 5.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Up-Regulation | 5 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 3 | 0.0 |
Antiviral Agents/pharmacology | 6 | 9.0 |
Cell Division | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Interferons/pharmacology | 2 | 2.0 |
Transfection | 21 | 0.0 |
Viral Structural Proteins/genetics/*metabolism | 2 | 66.0 |
Virus Replication | 6 | 0.0 |
*GTP-Binding Proteins | 3 | 5.0 |
*Intracellular Signaling Peptides and Proteins | 4 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
Signal Transduction/*physiology | 10 | 0.0 |
eIF-2 Kinase/metabolism | 2 | 14.0 |
Blotting, Western | 16 | 0.0 |
DNA-Binding Proteins/biosynthesis/genetics/*physiology | 2 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Signal Transduction/physiology | 6 | 0.0 |
Trans-Activators/genetics/*physiology | 2 | 2.0 |
Adenovirus E1A Proteins/metabolism | 2 | 6.0 |
Cysteine Endopeptidases/metabolism | 3 | 1.0 |
Gene Expression Regulation | 15 | 0.0 |
Genes, Reporter | 6 | 0.0 |
Histones/metabolism | 2 | 0.0 |
Macromolecular Substances | 7 | 0.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
Amino Acid Sequence | 20 | 0.0 |
Binding Sites | 16 | 0.0 |
Cytoplasm/metabolism | 6 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 3 | 1.0 |
Genetic Complementation Test | 2 | 0.0 |
Ligands | 6 | 0.0 |
Molecular Sequence Data | 34 | 0.0 |
Mutagenesis, Site-Directed | 8 | 0.0 |
Protein Structure, Tertiary | 10 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Trans-Activators/chemistry/*metabolism | 2 | 3.0 |
Transcription, Genetic | 11 | 0.0 |
Tyrosine/chemistry | 3 | 2.0 |
src Homology Domains | 6 | 1.0 |
Cell Division/genetics/immunology | 2 | 7.0 |
Comparative Study | 10 | 0.0 |
Enzyme Activation/immunology | 2 | 1.0 |
Histocompatibility Antigens Class I/biosynthesis | 2 | 4.0 |
Mice, Knockout | 5 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 4 | 4.0 |
Growth Inhibitors/pharmacology | 3 | 2.0 |
Interferon-beta/pharmacology | 2 | 4.0 |
*Milk Proteins | 13 | 2.0 |
Protein Biosynthesis | 4 | 0.0 |
Proteins/genetics | 4 | 0.0 |
Trans-Activators/*biosynthesis/genetics | 4 | 14.0 |
Cattle | 2 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Transcription Factors/metabolism | 13 | 0.0 |
Apoptosis | 4 | 0.0 |
Flow Cytometry | 5 | 0.0 |
Immunoblotting | 8 | 0.0 |
Interferon Type II/metabolism | 5 | 2.0 |
Precipitin Tests | 11 | 0.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
Time Factors | 10 | 0.0 |
Gene Expression Profiling | 5 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
*Down-Regulation | 3 | 0.0 |
Enzyme Activation | 11 | 0.0 |
Luciferases/metabolism | 6 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 9 | 1.0 |
Proteins/*metabolism | 5 | 0.0 |
Hela Cells | 22 | 0.0 |
Cell Cycle/drug effects | 2 | 0.0 |
Female | 7 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Antineoplastic Agents/*therapeutic use | 3 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Interferon-alpha/*therapeutic use | 2 | 3.0 |
Consensus Sequence | 2 | 0.0 |
DNA/genetics/metabolism | 3 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
In Vitro | 4 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Adult | 4 | 0.0 |
DNA-Binding Proteins/analysis | 2 | 2.0 |
Male | 6 | 0.0 |
Middle Aged | 2 | 0.0 |
Protein-Tyrosine Kinase/*analysis | 2 | 6.0 |
*Proto-Oncogene Proteins | 8 | 0.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Liver Neoplasms/*drug therapy/metabolism/pathology | 2 | 33.0 |
Protein Kinases/metabolism | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 5 | 0.0 |
Hematopoietic Stem Cells/*physiology | 2 | 1.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Tyrphostins/pharmacology | 2 | 1.0 |
DNA, Complementary | 3 | 0.0 |
Parainfluenza Virus 2, Human/genetics/metabolism/*pathogenicity | 2 | 100.0 |
Proteasome Endopeptidase Complex | 3 | 0.0 |
*Viral Proteins | 2 | 1.0 |
DNA-Binding Proteins/*antagonists & inhibitors/metabolism | 3 | 10.0 |
Interferons/*pharmacology | 6 | 8.0 |
Trans-Activators/*antagonists & inhibitors/metabolism | 3 | 15.0 |
Vero Cells | 5 | 2.0 |
Signal Transduction/*drug effects/physiology | 2 | 3.0 |
Hamsters | 2 | 0.0 |
Organ Specificity | 3 | 0.0 |
Phosphotyrosine/metabolism | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Gene Expression Regulation/*drug effects | 4 | 0.0 |
Transcription Factors/*genetics | 3 | 0.0 |
COS Cells | 2 | 0.0 |
Monocytes/metabolism | 2 | 0.0 |
*Protein-Tyrosine Kinase | 3 | 0.0 |
Receptors, Interferon/*metabolism | 4 | 14.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Interferon-alpha/*metabolism | 7 | 30.0 |
Mutation | 4 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Ribonucleases/metabolism | 2 | 1.0 |
Signal Transduction/*immunology | 3 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Interferons/*therapeutic use | 2 | 9.0 |
Amino Acid Substitution | 4 | 0.0 |
DNA-Binding Proteins/*chemistry/genetics/*metabolism | 2 | 3.0 |
Interferon Type II/*pharmacology | 6 | 1.0 |
Interferon-alpha/*pharmacology | 17 | 12.0 |
Liver Neoplasms | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Conformation | 4 | 0.0 |
Protein Transport | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Trans-Activators/*chemistry/genetics/*metabolism | 2 | 9.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Rabbits | 5 | 0.0 |
Receptors, Interferon/genetics | 2 | 12.0 |
Trans-Activators/genetics | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 4 | 0.0 |
Drug Synergism | 2 | 0.0 |
Interferon Type II/pharmacology | 6 | 1.0 |
Signal Transduction/drug effects | 4 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Interferon-alpha/pharmacology | 10 | 10.0 |
Interferon-gamma, Recombinant/pharmacology | 3 | 1.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Recombinant Proteins/pharmacology | 4 | 0.0 |
Structure-Activity Relationship | 5 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Infant | 2 | 0.0 |
Interferon Type I/*physiology | 2 | 20.0 |
Serine/metabolism | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Cell Line, Tumor | 8 | 0.0 |
Interferons/*antagonists & inhibitors/metabolism | 2 | 100.0 |
Amino Acid Motifs | 3 | 0.0 |
Conserved Sequence/genetics | 2 | 1.0 |
Molecular Weight | 4 | 0.0 |
Trans-Activators/antagonists & inhibitors/*metabolism | 3 | 13.0 |
Antiviral Agents/*pharmacology | 4 | 2.0 |
DNA/metabolism | 6 | 0.0 |
Mutagenesis | 2 | 0.0 |
*Transcription, Genetic | 5 | 0.0 |
Nuclear Proteins/*genetics/metabolism | 2 | 1.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
Trans-Activators/*genetics/metabolism | 7 | 6.0 |
Chromatin/metabolism | 3 | 1.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
Hydroxamic Acids/pharmacology | 2 | 1.0 |
Interferons/*metabolism | 2 | 11.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 7 | 1.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Protein-Tyrosine Kinase | 2 | 5.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 4 | 2.0 |
Interferons/metabolism | 4 | 17.0 |
Karyopherins/metabolism | 2 | 9.0 |
Trans-Activators/chemistry/genetics/*metabolism | 5 | 6.0 |
Cell Line, Transformed | 3 | 0.0 |
DNA-Binding Proteins/*biosynthesis/*metabolism | 2 | 40.0 |
*Gene Expression Regulation | 2 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
Cytokines/metabolism | 4 | 0.0 |
Interferon Type II/*metabolism | 2 | 3.0 |
Interferon Type II/*physiology | 2 | 3.0 |
Up-Regulation/drug effects | 3 | 0.0 |
Glutathione Transferase/genetics/metabolism | 2 | 1.0 |
Peptide Fragments/chemistry/genetics/metabolism | 2 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Oligodeoxyribonucleotides | 4 | 0.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Interferon Alfa-2a/pharmacology | 2 | 25.0 |
Signal Transduction/drug effects/immunology | 2 | 4.0 |
Prolactin/*pharmacology | 2 | 2.0 |
Gene Expression Regulation/drug effects/*immunology | 2 | 6.0 |
Protein-Tyrosine Kinase/*physiology | 2 | 1.0 |
Signal Transduction/*drug effects | 7 | 1.0 |
Inflammation | 4 | 1.0 |
RNA Interference | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Interferon-alpha/immunology | 2 | 25.0 |
Th1 Cells/cytology/*immunology | 2 | 20.0 |
Trans-Activators/genetics/metabolism | 2 | 1.0 |
Receptors, Interferon/chemistry/genetics/*physiology | 2 | 100.0 |
Blotting, Northern | 2 | 0.0 |
Trans-Activation (Genetics)/*drug effects | 4 | 4.0 |
Models, Biological | 5 | 0.0 |
Receptors, Interferon/chemistry/genetics/*metabolism | 2 | 25.0 |
Interferon-alpha/*physiology | 2 | 15.0 |
Sequence Analysis, DNA | 2 | 0.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Recombinant Fusion Proteins/*pharmacology | 2 | 8.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Reticulocytes/metabolism | 2 | 2.0 |
Viral Structural Proteins/*metabolism | 3 | 42.0 |
Antibodies | 2 | 0.0 |
Interferon-gamma, Recombinant/*pharmacology | 3 | 2.0 |
Sequence Deletion | 3 | 0.0 |
Phosphotyrosine/analysis | 2 | 3.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/isolation & purification/*metabolism | 2 | 13.0 |
*Neoplasm Proteins | 2 | 0.0 |
Thrombopoietin/*pharmacology | 2 | 2.0 |
Receptors, Cytokine/metabolism | 3 | 3.0 |
Phosphotyrosine | 3 | 1.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
RNA/metabolism | 4 | 0.0 |
Interleukin-6/metabolism | 3 | 1.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Models, Immunological | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
